A Biotechnology firm which has pioneered technology that will advance stem cell research and could lead to a cut in the number of medical tests on people and animals has won £1.6m of investment.
Reinnervate has been researching its...
What is the focus of the Fund?
The Fund invests in proof of concept/early stage technology deals where the first round might be up to
£350k drawn down in tranches.
The funds have the capacity to follow on up to £1m and beyond and will often seek to co-invest.
Investments are usually from £50k to £1m.
Who can apply?
Seed and start-up technology companies or pre-IPO with unique technologies and exceptional prospects.
Where can I get more information?
The Fund is managed by:
Enterprise Ventures Limited
1 Whitehall
Whitehall Road
Leeds LS1 4HR
Contact Paul Betts
Tel: 07540 014 911
www.evgroup.uk.com
